Get started
Author

Ke Fu

ORCID: 0000-0003-4511-424X
Observed ORCID: 0000-0003-4511-424X
OpenAlex ID: A5087288951
Macrophage Polarization and Its Role in Liver Disease
2021 · Cheng Wang, Cheng Ma, et al. · Frontiers in Immunology · 603
PDF
Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
2023 · Cheng Wang, Shu Dai, et al. · Biomedicine & Pharmacotherapy · 159
Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics
2022 · Shu Dai, Cheng Wang, et al. · Pharmacological Research · 121
PDF
Progress in ICP-MS Analysis of Minerals and Heavy Metals in Traditional Medicine
2022 · Wanyue Chen, Yichu Yang, et al. · Frontiers in Pharmacology · 93
PDF
CD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated Pyroptosis
2023 · Lihong Gong, Honglin Zhou, et al. · Advanced Healthcare Materials · 92
PDF
Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
2023 · Chenhao Yao, Shu Dai, et al. · Biomedicine & Pharmacotherapy · 83
Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
2021 · Cheng Wang, Cheng Ma, et al. · Frontiers in Pharmacology · 69
PDF
The Status quo and way forwards on the development of Tibetan medicine and the pharmacological research of tibetan materia Medica
2020 · Ke Fu, Min Xu, et al. · Pharmacological Research · 67
Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p
2023 · Cheng Ma, Cheng Wang, et al. · Biomedicine & Pharmacotherapy · 65
A review: Pharmacology and pharmacokinetics of Schisandrin A
2022 · Ke Fu, Honglin Zhou, et al. · Phytotherapy Research · 61
Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder
2022 · Ke Fu, Cheng Ma, et al. · Biomedicine & Pharmacotherapy · 59
The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity
2021 · Ke Fu, Cheng Wang, et al. · Frontiers in Pharmacology · 54
PDF
Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of Erigeron breviscapus
2021 · Ruixia Wu, Yan Liang, et al. · Frontiers in Pharmacology · 49
PDF
Traditional medicine in China for ischemic stroke: bioactive components, pharmacology, and mechanisms
2022 · Min Xu, Rui-Xia Wu, et al. · Journal of Integrative Neuroscience · 48
PDF
Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations
2023 · Yafang Zhang, Ke Fu, et al. · Food & Function · 43
Comparison of medicinal preparations of Ayurveda in India and five traditional medicines in China
2021 · Xiaoli Li, Lei Wu, et al. · Journal of Ethnopharmacology · 42
Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism
2022 · Cheng Wang, Cheng Ma, et al. · Journal of Ethnopharmacology · 39
Protective effect and mechanism of Qishiwei Zhenzhu pills on cerebral ischemia-reperfusion injury via blood-brain barrier and metabonomics
2020 · Min Xu, Ruixia Wu, et al. · Biomedicine & Pharmacotherapy · 39
PDF
Mesenchymal stem cell-derived exosomes and non-coding RNAs: Regulatory and therapeutic role in liver diseases
2022 · Cheng Wang, Honglin Zhou, et al. · Biomedicine & Pharmacotherapy · 32
PDF
A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside
2022 · Cheng Wang, Shu Dai, et al. · Frontiers in Pharmacology · 29
PDF
Tetramethylpyrazine Protects Endothelial Injury and Antithrombosis via Antioxidant and Antiapoptosis in HUVECs and Zebrafish
2022 · Yafang Zhang, Cheng Ma, et al. · Oxidative Medicine and Cellular Longevity · 27
PDF
The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis
2023 · Xinyan Xue, Jing Wang, et al. · International Immunopharmacology · 26
Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway
2023 · Cheng Wang, Yanfang Liu, et al. · Inflammation · 25
Exploring the effect and mechanism of cucurbitacin B on cholestatic liver injury based on network pharmacology and experimental verification
2023 · Shu Dai, Rui Wu, et al. · Journal of Ethnopharmacology · 23
Preparation of Phillygenin-Hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect
2023 · Lihong Gong, Honglin Zhou, et al. · Materials Today Bio · 23
Works count: 37
Citation count: 2,090
H-index: 23
I10-index: 32
Year
Topic
Type